Department of Internal Medicine I, Paracelsus Medical University/Salzburger Landeskliniken, Muellner Hauptstrasse 48, 5020 Salzburg, Austria.
Biomed Res Int. 2013;2013:840417. doi: 10.1155/2013/840417. Epub 2013 May 16.
In vitro research performed on eukaryotic or prokaryotic cell cultures usually represents the initial step for characterization of a novel photosensitizer (PS) intended for application in photodynamic therapy (PDT) of cancer or photodynamic inactivation (PDI) of microorganisms. Although many experimental steps of PS testing make use of the wide spectrum of methods readily employed in cell biology, special aspects of working with photoactive substances, such as the autofluorescence of the PS molecule or the requirement of light protection, need to be considered when performing in vitro experiments in PDT/PDI. This tutorial represents a comprehensive collection of operative instructions, by which, based on photochemical and photophysical properties of a PS, its uptake into cells, the intracellular localization and photodynamic action in both tumor cells and microorganisms novel photoactive molecules may be characterized for their suitability for PDT/PDI. Furthermore, it shall stimulate the efforts to expand the convincing benefits of photodynamic therapy and photodynamic inactivation within both established and new fields of applications and motivate scientists of all disciplines to get involved in photodynamic research.
在真核或原核细胞培养物上进行的体外研究通常代表了用于癌症光动力疗法 (PDT) 或微生物光动力失活 (PDI) 的新型光敏剂 (PS) 特性描述的初始步骤。尽管 PS 测试的许多实验步骤都利用了细胞生物学中广泛使用的方法,但在 PDT/PDI 中进行体外实验时,需要考虑到与光活性物质相关的特殊方面,例如 PS 分子的自发荧光或光保护的要求。本教程代表了一套全面的操作说明,根据 PS 的光化学和光物理特性,通过这些说明可以对其摄取到细胞内的情况、细胞内定位以及在肿瘤细胞和微生物中的光动力作用进行描述,从而确定新型光活性分子是否适合 PDT/PDI。此外,它将激励人们在既定和新的应用领域中扩大光动力疗法和光动力失活的令人信服的益处,并促使各学科的科学家参与光动力研究。